Developer docs
API playgroundTry for free, no card

Search company profiles

MassBio

Full company profile

uuid003xwyz

Namestring
MassBio
Legal namestring
Massachusetts Biotechnology Council
Websiteurl
massbio.org
Company typeenum
Private
Founded yearint
1985
Descriptiontext

MassBio (legally the Massachusetts Biotechnology Council) is a non-profit 501(c)(6) trade association founded in 1985 and headquartered at 700 Technology Square, 5th Floor, Cambridge, Massachusetts. It represents 1,700+ member companies across the Massachusetts life sciences ecosystem, spanning biotech, pharmaceutical, biomanufacturing, academic and research institutions, disease foundations, and service providers. Its mission is to advance Massachusetts' leadership in life sciences through policy advocacy from Beacon Hill to Capitol Hill, workforce development, networking, and operational support for member companies.

MassBio operates a platform of interconnected programs rather than a single product. Core offerings include: MassBioEdge, a group-purchasing consortium generating over $300M in annual member savings through preferred-vendor agreements with Veolia, Middlesex Gases, ACS, and others; the Drive accelerator (in partnership with SCbio), an eight-week hybrid program that has supported 59 companies raising $290M since 2022 and added a techbio cohort in May 2025; Termeer Ascend, a leadership development program co-developed with The Termeer Institute for executives aspiring to C-suite roles; the Bioversity workforce training center providing free skills development; MassBioHub, a conference facility at the Cambridge headquarters; CEO & Founder Link peer networking; the BioReady Communities municipal designation program; and major annual events including the State of Possible Conference and Align Summit.

Revenue is generated primarily through annual membership dues across tiers, event sponsorships and registrations (State of Possible, Align Summit, Pharma Days), accelerator program fees, facility rentals at MassBioHub, and preferred-partner referral economics through MassBioEdge. Go-to-market is sales-led via a membership portal and direct outreach, supplemented by event-driven engagement (70+ partnering events annually). Leadership includes CEO & President Kendalle Burlin O'Connell, Chief Operating and Innovation Officer Jason Cordeiro, and Board Chair Charles Wilson (Immediate Past Chair). The organization operates under a Vision 2030 five-year strategic plan launched in 2024 and is governed by a Board of Directors without external parent ownership.

Short descriptiontext

MassBio (Massachusetts Biotechnology Council) is a non-profit trade association founded in 1985, representing 1,700+ life sciences companies in Massachusetts through policy advocacy, workforce training, group purchasing, networking events, and the Drive accelerator program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotechnology trade association, life sciences membership, biopharma policy advocacy, industry networking events, startup accelerator programs
NAICS code2 codes
  • Business Associations81391
  • Professional Organizations813920
SIC code1 code
  • Services-Membership Organizations8600
Product category
Biotechnology Trade Association
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Membership Dues
TypeSubscription Recurring
Description

MassBio generates revenue through annual membership dues from 1,700+ member companies across the life sciences ecosystem. Membership tiers offer varying benefits including access to events, advocacy, workforce programs, and group purchasing savings.

massbio.org
2Event Sponsorships and Registration
TypeSubscription Recurring
Description

Revenue from sponsoring and attending major conferences including State of Possible Conference, Align Summit, and Pharma Days. Sponsors receive brand visibility, complimentary registrations, and dedicated partnering table access.

massbio.org
3MassBioEdge Group Purchasing
TypeAffiliate Referral
Description

The MassBioEdge program generates value through collective purchasing power, saving members over $300 million annually on critical products and services. While the savings flow to members, the program strengthens membership value proposition and retention.

massbio.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Operations, Technology or R&D, Others
Pricing details1 tier
1Standard membership for life sciences companies
ModelSubscriptionBilling cadenceAnnual
Notes

Membership dues vary by company type and size. Companies can select from types and rates detailed at massbio.org/membership/pricing/

massbio.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 8 records shown
1MassBioEdge
Description

Empowered purchasing program that helps member companies save on essential supplies and services with exclusive discounts, better terms, and personalized support. Has generated over $300M in annual savings for members.

massbio.org
+7 more records
Core offering1 text field

MassBio (Massachusetts Biotechnology Council) is a 501(c)(6) non-profit trade association representing 1,700+ life sciences member companies. It sells annual membership subscriptions and delivers a portfolio of member services including group purchasing savings (MassBioEdge), startup acceleration (Drive), annual conferences (State of Possible, Align Summit), conference center rentals (MassBioHub), leadership development (Termeer Ascend), workforce training (Bioversity), career services, and policy advocacy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • $300 million+ in annual member savings through group purchasing
+3 more records
Product overview1 text field

MassBio is a membership-based industry association (Massachusetts Biotechnology Council) serving as the premier global life sciences and healthcare hub, with 1,700+ member companies. Rather than a unified software product, MassBio operates as a platform of interconnected programs and services including: MassBioEdge for collective purchasing savings; Drive Accelerator for startup acceleration; State of Possible Conference and Align Summit for industry events; MassBioHub as a conference facility; Termeer Ascend for leadership development; CEO & Founder Link for peer networking; Bioversity for workforce training; BioReady Communities for municipal certification; Vision 2030 as strategic planning framework; Career Center for talent recruitment; and Industry Reports for market intelligence. These offerings work together to advance Massachusetts' leadership in life sciences by providing advocacy, education, networking, cost savings, and industry information to members at all stages of the biopharma lifecycle.

Product and service10 records
1MassBio Membership
CategoryMembership
Description

Annual membership subscription for life sciences companies (biotech, pharma, biomanufacturing, academic institutions, research hospitals, disease foundations, service providers) providing access to events, advocacy, group purchasing, workforce programs, and networking.

2MassBioEdge
CategoryGroup Purchasing
Description

Group purchasing consortium offering preferred vendor pricing on supplies and services, generating over $300 million in annual savings for member companies across the life sciences ecosystem.

3Drive Accelerator
CategoryAccelerator Program
Description

National accelerator program for early-stage life sciences companies offering an eight-week hybrid curriculum with mentor matching, networking, and demo days across biotech and techbio tracks.

4State of Possible Conference
CategoryConference
Description

Annual premier life sciences conference bringing together industry leaders, policymakers, researchers, and patient advocates to discuss innovation and Massachusetts' role as a global biotech hub.

5Align Summit
CategoryPartnering Conference
Description

Annual partnering conference building relationships between funders and biotech startups through seed/Series A company presentations, keynotes, panels, and one-on-one partnering meetings.

6MassBioHub Conference Center
CategoryFacility Rental
Description

Conference center facility at 700 Technology Square, Cambridge, offering meeting spaces and event packages for member events and industry gatherings.

7Termeer Ascend
CategoryLeadership Development
Description

Leadership development program for senior biotech leaders aspiring to C-suite roles, developed in partnership with The Termeer Institute, covering values-driven leadership, technical skills, and executive readiness.

8CEO & Founder Link
CategoryNetworking Program
Description

Peer networking program connecting biotech founders and CEOs for collaboration and shared learning within the Massachusetts life sciences ecosystem.

9Bioversity Workforce Training
CategoryWorkforce Training
Description

Workforce training center providing skills development programs for life sciences careers, designed to diversify the biotech workforce and improve access for underrepresented populations.

10Career Center
CategoryTalent Service
Description

Job posting and career connection service allowing members to post life sciences openings at discounted rates and connect with talent in the sector.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1The Termeer Institute
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MassBio and The Termeer Institute co-developed Termeer Ascend, a leadership development program for senior biotech leaders aspiring to the C-suite. The program addresses critical talent gaps with over 90% of Massachusetts biopharma companies reporting difficulty hiring for non-entry-level roles and 86% lacking succession strategies. The initiative aims to diversify and strengthen the leadership pipeline.

bizjournals.com
2SCbio
Strategic tierCoreTypeStrategic or Co-development Partner
Description

National accelerator partnership between MassBio and SCbio to deliver the Drive program. The Spring 2026 cohort includes 11 startups split between biotech (MassBio-led) and biomarkers/diagnostics (SCbio-led) tracks. Since 2022, Drive has supported 59 companies raising $290 million.

massbio.org
Strategic tierMajorTypeGTM or Marketing Partner
Description

MassBio collaborated with Novartis to host the Novartis Partnering Forum at Novartis headquarters in Cambridge, targeting senior biotech executives and C-level leaders. The forum featured discussions on external innovation, VC financing, and successful partnering examples.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MassBio and Google partnered to deliver customized AI training for biotech workers focused on AI for Drug Discovery. Google also sponsors the Drive accelerator techbio cohort. This partnership addresses the growing role of AI in drug development.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Over 20-year partnership where Veolia provides waste management, environmental, and sustainability solutions to MassBio members. Expanded agreement includes building energy management and decarbonization services. Veolia offers these services to MassBio's 1,700+ member companies at preferred rates.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

ACS became a MassBioEdge Preferred Partner for managed IT and cybersecurity services. The partnership provides MassBio members with enterprise-level IT solutions, 24/7 managed services, network security, and compliance support for HIPAA, FDA, and regulatory standards.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

7-year contract extending partnership through 2030 for gas cylinder safety training and gas supply services to MassBio members. Partnership supports workforce training and safety compliance for life sciences companies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership announced to strengthen the life sciences ecosystem through collaboration on shared operational excellence initiatives for laboratory operations professionals.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership announced January 2026 to collaborate on initiatives supporting the Kendall Square innovation district and broader Massachusetts life sciences ecosystem.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Partner for the Drive accelerator program, providing curriculum expertise and mentoring for early-stage life sciences companies. F-Prime Capital contributes industry expertise to the techbio and biotech cohorts.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Legal counsel partner for the Drive accelerator program, providing curriculum expertise and mentoring for early-stage life sciences companies navigating legal and regulatory challenges.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Curriculum expert partner for the Drive accelerator program, contributing strategic consulting expertise to the techbio and biotech startup cohorts.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Analytics and insights partner sponsoring the Drive accelerator techbio cohort, providing data and intelligence services to early-stage life sciences companies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BioNJ is New Jersey's life sciences trade association representing one of the largest U.S. biotech clusters. It is structurally analogous to MassBio with similar advocacy, networking, and member services offerings focused on a regional ecosystem.

TypeDirect peer
Description

Life Sciences Pennsylvania is a regional life sciences trade association representing Pennsylvania's biotech and medical device industries. It is a state-level peer with comparable advocacy, networking, and policy engagement functions.

TypeDirect peer
Description

California Life Sciences is the largest state-level life sciences trade association, representing California's biotech ecosystem. It is the most direct regional counterpart to MassBio, competing for member attention, sponsorships, and policy influence across the U.S. biotech landscape.

TypeBroad incumbent
Description

PhRMA is the national pharmaceutical industry trade association. It overlaps with MassBio in policy advocacy, member services, and event programming for life sciences companies, but focuses on the larger pharmaceutical manufacturer segment rather than early-stage biotech.

TypeDirect peer
Description

BioFlorida is Florida's statewide life sciences trade association. It mirrors MassBio's regional association model with member services, advocacy, and networking programs targeting the Florida biotech and pharma cluster.

TypeRegional player
Description

MassMEDIC is the Massachusetts medical device industry trade association. It is a regional peer operating in the same geography as MassBio but focused specifically on the medical device and digital health sub-segment of the life sciences industry.

TypeDirect peer
Description

BioOhio is Ohio's life sciences industry trade association. As a state-level peer with advocacy, member programs, and partnering events, it offers a comparable model to MassBio at smaller scale within a different regional cluster.

TypeBroad incumbent
Description

BIO is the largest U.S. biotechnology trade association with national and global reach. Like MassBio, it represents life sciences companies, advocates for policy, runs partnering conferences (BIO Convention), and provides member services — but at a national scale and broader industry scope.

TypeBroad incumbent
Description

AdvaMed is the national medical technology industry association. It overlaps with MassBio in serving life sciences companies through advocacy, networking, and member services but specializes in medical devices and diagnostics rather than biotech/pharma.

10SCbio
TypeDirect peer
Description

SCbio is South Carolina's life sciences industry association and a current partner of MassBio on the Drive accelerator program. It is a regional trade association directly comparable in structure and mission to MassBio, representing the SC life sciences cluster.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MassBio

Biotechnology Trade Associationmassbio.org

MassBio (Massachusetts Biotechnology Council) is a non-profit trade association founded in 1985, representing 1,700+ life sciences companies in Massachusetts through policy advocacy, workforce training, group purchasing, networking events, and the Drive accelerator program.

What MassBio does

MassBio (legally the Massachusetts Biotechnology Council) is a non-profit 501(c)(6) trade association founded in 1985 and headquartered at 700 Technology Square, 5th Floor, Cambridge, Massachusetts. It represents 1,700+ member companies across the Massachusetts life sciences ecosystem, spanning biotech, pharmaceutical, biomanufacturing, academic and research institutions, disease foundations, and service providers. Its mission is to advance Massachusetts' leadership in life sciences through policy advocacy from Beacon Hill to Capitol Hill, workforce development, networking, and operational support for member companies.

MassBio operates a platform of interconnected programs rather than a single product. Core offerings include: MassBioEdge, a group-purchasing consortium generating over $300M in annual member savings through preferred-vendor agreements with Veolia, Middlesex Gases, ACS, and others; the Drive accelerator (in partnership with SCbio), an eight-week hybrid program that has supported 59 companies raising $290M since 2022 and added a techbio cohort in May 2025; Termeer Ascend, a leadership development program co-developed with The Termeer Institute for executives aspiring to C-suite roles; the Bioversity workforce training center providing free skills development; MassBioHub, a conference facility at the Cambridge headquarters; CEO & Founder Link peer networking; the BioReady Communities municipal designation program; and major annual events including the State of Possible Conference and Align Summit.

Revenue is generated primarily through annual membership dues across tiers, event sponsorships and registrations (State of Possible, Align Summit, Pharma Days), accelerator program fees, facility rentals at MassBioHub, and preferred-partner referral economics through MassBioEdge. Go-to-market is sales-led via a membership portal and direct outreach, supplemented by event-driven engagement (70+ partnering events annually). Leadership includes CEO & President Kendalle Burlin O'Connell, Chief Operating and Innovation Officer Jason Cordeiro, and Board Chair Charles Wilson (Immediate Past Chair). The organization operates under a Vision 2030 five-year strategic plan launched in 2024 and is governed by a Board of Directors without external parent ownership.

MassBio firmographics

Firmographics
Name
MassBio
Legal name
Massachusetts Biotechnology Council
Website
https://massbio.org
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
11–50 employees
Short description
MassBio (Massachusetts Biotechnology Council) is a non-profit trade association founded in 1985, representing 1,700+ life sciences companies in Massachusetts through policy advocacy, workforce training, group purchasing, networking events, and the Drive accelerator program.
Ownership category
akta.pro rank

Where MassBio is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MassBio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

  1. Membership Dues: MassBio generates revenue through annual membership dues from 1,700+ member companies across the life sciences ecosystem. Membership tiers offer varying benefits including access to events, advocacy, workforce programs, and group purchasing savings.
  2. Event Sponsorships and Registration: Revenue from sponsoring and attending major conferences including State of Possible Conference, Align Summit, and Pharma Days. Sponsors receive brand visibility, complimentary registrations, and dedicated partnering table access.
  3. MassBioEdge Group Purchasing: The MassBioEdge program generates value through collective purchasing power, saving members over $300 million annually on critical products and services. While the savings flow to members, the program strengthens membership value proposition and retention.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStandard membership for life sciences companies

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

MassBio product offering

Product offering

Core offering

MassBio (Massachusetts Biotechnology Council) is a 501(c)(6) non-profit trade association representing 1,700+ life sciences member companies. It sells annual membership subscriptions and delivers a portfolio of member services including group purchasing savings (MassBioEdge), startup acceleration (Drive), annual conferences (State of Possible, Align Summit), conference center rentals (MassBioHub), leadership development (Termeer Ascend), workforce training (Bioversity), career services, and policy advocacy.

Product overview

MassBio is a membership-based industry association (Massachusetts Biotechnology Council) serving as the premier global life sciences and healthcare hub, with 1,700+ member companies. Rather than a unified software product, MassBio operates as a platform of interconnected programs and services including: MassBioEdge for collective purchasing savings; Drive Accelerator for startup acceleration; State of Possible Conference and Align Summit for industry events; MassBioHub as a conference facility; Termeer Ascend for leadership development; CEO & Founder Link for peer networking; Bioversity for workforce training; BioReady Communities for municipal certification; Vision 2030 as strategic planning framework; Career Center for talent recruitment; and Industry Reports for market intelligence. These offerings work together to advance Massachusetts' leadership in life sciences by providing advocacy, education, networking, cost savings, and industry information to members at all stages of the biopharma lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

  • MassBioEdge: Empowered purchasing program that helps member companies save on essential supplies and services with exclusive discounts, better terms, and personalized support. Has generated over $300M in annual savings for members.
  • MassBioHub
  • Drive
  • Termeer Ascend
  • Align Summit
  • Bioversity
  • Vision 2030
  • State of Possible Conference

Products and services

  • MassBio Membership Annual membership subscription for life sciences companies (biotech, pharma, biomanufacturing, academic institutions, research hospitals, disease foundations, service providers) providing access to events, advocacy, group purchasing, workforce programs, and networking.
  • MassBioEdge Group purchasing consortium offering preferred vendor pricing on supplies and services, generating over $300 million in annual savings for member companies across the life sciences ecosystem.
  • Drive Accelerator National accelerator program for early-stage life sciences companies offering an eight-week hybrid curriculum with mentor matching, networking, and demo days across biotech and techbio tracks.
  • State of Possible Conference Annual premier life sciences conference bringing together industry leaders, policymakers, researchers, and patient advocates to discuss innovation and Massachusetts' role as a global biotech hub.
  • Align Summit Annual partnering conference building relationships between funders and biotech startups through seed/Series A company presentations, keynotes, panels, and one-on-one partnering meetings.
  • MassBioHub Conference Center Conference center facility at 700 Technology Square, Cambridge, offering meeting spaces and event packages for member events and industry gatherings.
  • Termeer Ascend Leadership development program for senior biotech leaders aspiring to C-suite roles, developed in partnership with The Termeer Institute, covering values-driven leadership, technical skills, and executive readiness.
  • CEO & Founder Link Peer networking program connecting biotech founders and CEOs for collaboration and shared learning within the Massachusetts life sciences ecosystem.
  • Bioversity Workforce Training Workforce training center providing skills development programs for life sciences careers, designed to diversify the biotech workforce and improve access for underrepresented populations.
  • Career Center Job posting and career connection service allowing members to post life sciences openings at discounted rates and connect with talent in the sector.

Quantifiable outcome

  • $300 million+ in annual member savings through group purchasing
  • +3 more outcomes

Companies that use MassBio

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

MassBio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MassBio partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core, major and minor.

  • The Termeer InstitutecoreStrategic or Co-development PartnerMassBio and The Termeer Institute co-developed Termeer Ascend, a leadership development program for senior biotech leaders aspiring to the C-suite. The program addresses critical talent gaps with over 90% of Massachusetts biopharma companies reporting difficulty hiring for non-entry-level roles and 86% lacking succession strategies. The initiative aims to diversify and strengthen the leadership pipeline.
  • SCbiocoreStrategic or Co-development PartnerNational accelerator partnership between MassBio and SCbio to deliver the Drive program. The Spring 2026 cohort includes 11 startups split between biotech (MassBio-led) and biomarkers/diagnostics (SCbio-led) tracks. Since 2022, Drive has supported 59 companies raising $290 million.
  • NovartismajorGTM or Marketing PartnerMassBio collaborated with Novartis to host the Novartis Partnering Forum at Novartis headquarters in Cambridge, targeting senior biotech executives and C-level leaders. The forum featured discussions on external innovation, VC financing, and successful partnering examples.
  • GooglecoreStrategic or Co-development PartnerMassBio and Google partnered to deliver customized AI training for biotech workers focused on AI for Drug Discovery. Google also sponsors the Drive accelerator techbio cohort. This partnership addresses the growing role of AI in drug development.
  • Veolia North AmericamajorChannel Partner/ Reseller/ DistributorOver 20-year partnership where Veolia provides waste management, environmental, and sustainability solutions to MassBio members. Expanded agreement includes building energy management and decarbonization services. Veolia offers these services to MassBio's 1,700+ member companies at preferred rates.
  • ACS (Advanced Computer Systems)majorChannel Partner/ Reseller/ DistributorACS became a MassBioEdge Preferred Partner for managed IT and cybersecurity services. The partnership provides MassBio members with enterprise-level IT solutions, 24/7 managed services, network security, and compliance support for HIPAA, FDA, and regulatory standards.
  • Middlesex GasesmajorChannel Partner/ Reseller/ Distributor7-year contract extending partnership through 2030 for gas cylinder safety training and gas supply services to MassBio members. Partnership supports workforce training and safety compliance for life sciences companies.
  • LabOps UniteminorStrategic or Co-development PartnerPartnership announced to strengthen the life sciences ecosystem through collaboration on shared operational excellence initiatives for laboratory operations professionals.
  • Kendall Square AssociationminorStrategic or Co-development PartnerStrategic partnership announced January 2026 to collaborate on initiatives supporting the Kendall Square innovation district and broader Massachusetts life sciences ecosystem.
  • F-Prime CapitalcoreGTM or Marketing PartnerPartner for the Drive accelerator program, providing curriculum expertise and mentoring for early-stage life sciences companies. F-Prime Capital contributes industry expertise to the techbio and biotech cohorts.
  • Wilson Sonsini Goodrich & RosaticoreGTM or Marketing PartnerLegal counsel partner for the Drive accelerator program, providing curriculum expertise and mentoring for early-stage life sciences companies navigating legal and regulatory challenges.
  • Browne ConsultingcoreGTM or Marketing PartnerCurriculum expert partner for the Drive accelerator program, contributing strategic consulting expertise to the techbio and biotech startup cohorts.
  • EvaluatecoreGTM or Marketing PartnerAnalytics and insights partner sponsoring the Drive accelerator techbio cohort, providing data and intelligence services to early-stage life sciences companies.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

MassBio competitors and assessment

Company assessment

Direct peers

  • BioNJ: BioNJ is New Jersey's life sciences trade association representing one of the largest U.S. biotech clusters. It is structurally analogous to MassBio with similar advocacy, networking, and member services offerings focused on a regional ecosystem.
  • Life Sciences Pennsylvania: Life Sciences Pennsylvania is a regional life sciences trade association representing Pennsylvania's biotech and medical device industries. It is a state-level peer with comparable advocacy, networking, and policy engagement functions.
  • California Life Sciences (CLS): California Life Sciences is the largest state-level life sciences trade association, representing California's biotech ecosystem. It is the most direct regional counterpart to MassBio, competing for member attention, sponsorships, and policy influence across the U.S. biotech landscape.
  • BioFlorida: BioFlorida is Florida's statewide life sciences trade association. It mirrors MassBio's regional association model with member services, advocacy, and networking programs targeting the Florida biotech and pharma cluster.
  • BioOhio: BioOhio is Ohio's life sciences industry trade association. As a state-level peer with advocacy, member programs, and partnering events, it offers a comparable model to MassBio at smaller scale within a different regional cluster.
  • SCbio: SCbio is South Carolina's life sciences industry association and a current partner of MassBio on the Drive accelerator program. It is a regional trade association directly comparable in structure and mission to MassBio, representing the SC life sciences cluster.

Broad incumbents

  • PhRMA: PhRMA is the national pharmaceutical industry trade association. It overlaps with MassBio in policy advocacy, member services, and event programming for life sciences companies, but focuses on the larger pharmaceutical manufacturer segment rather than early-stage biotech.
  • Biotechnology Innovation Organization (BIO): BIO is the largest U.S. biotechnology trade association with national and global reach. Like MassBio, it represents life sciences companies, advocates for policy, runs partnering conferences (BIO Convention), and provides member services — but at a national scale and broader industry scope.
  • AdvaMed: AdvaMed is the national medical technology industry association. It overlaps with MassBio in serving life sciences companies through advocacy, networking, and member services but specializes in medical devices and diagnostics rather than biotech/pharma.

Regional players

  • MassMEDIC: MassMEDIC is the Massachusetts medical device industry trade association. It is a regional peer operating in the same geography as MassBio but focused specifically on the medical device and digital health sub-segment of the life sciences industry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

MassBio social profiles

Digital presence

MassBio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MassBio leadership team

Management profile

Number of profiles

Profiles1 record

MassBio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MassBio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MassBio

What does MassBio do?

MassBio (Massachusetts Biotechnology Council) is a 501(c)(6) non-profit trade association representing 1,700+ life sciences member companies. It sells annual membership subscriptions and delivers a portfolio of member services including group purchasing savings (MassBioEdge), startup acceleration (Drive), annual conferences (State of Possible, Align Summit), conference center rentals (MassBioHub), leadership development (Termeer Ascend), workforce training (Bioversity), career services, and policy advocacy.

Is MassBio a public or private company?

MassBio is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was MassBio founded?

MassBio was founded in 1985. It employs 11 to 50 people.

Where is MassBio based?

MassBio is headquartered in Cambridge, United States, in the North America region.

How does MassBio make money?

Three revenue lines are on record. Membership Dues are the primary driver. The others are event Sponsorships and Registration and massBioEdge Group Purchasing.

Who are MassBio's main competitors?

Direct peers on record are BioNJ, Life Sciences Pennsylvania, California Life Sciences (CLS), BioFlorida, BioOhio and SCbio. Broad incumbents are PhRMA, Biotechnology Innovation Organization (BIO) and AdvaMed. MassMEDIC is listed as a regional player.

Does MassBio have an API?

No public API is recorded for MassBio.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpace10 life sciences startups selected for accelerator programMassBio and SCbio selected 10 startups for their Drive accelerator program, covering biotechs and techbios. The free eight-week program includes mentorship, demo days, and a sponsored lab bench for one graduate. Since 2022, Drive has supported 70 companies that raised $137 million.MassbioBoston Business Journal: Biotech jobs dropped for the first time in 2025. Can rebounding VC, M&A bring them back?Massachusetts' biopharma workforce contracted 3.1% in 2025, a 3,600-job decline reported in the MassBio 2026 Industry Snapshot, the first year-over-year drop since the 2008 Life Sciences Initiative. The state's biopharma workforce had grown roughly 109% since 2008. MassBio head Ben Bradford said first-half 2026 deals, capital and exits returned to the sector, with hope that Q1 2026 workforce numbers beat Q4 2025.BioPharma DiveYoung startups miss out on biotech venture funding rebound, MassBio saysMassBio, Massachusetts' biopharmaceutical trade association, reported that Massachusetts drugmakers raised nearly $3.5 billion in venture funding in the first half of 2026, up 25% from 2025, with eight Boston-area biotechs pricing IPOs. Seed rounds averaged $4.65 million while Series A funding reached nearly $80 million. The report also noted China's drug pipeline grew 36.2% year over year, surpassing Europe.WBURMass. biopharma industry loses jobs, but investment reboundsMassBio released a report Tuesday showing Massachusetts' biopharma industry cut about 3,600 jobs in 2025, the first decline in over two decades, with losses concentrated in research and development. Venture capital funding rose 25% in the first half of the year to $3.45 billion, and eight biopharma companies went public.FierceBiotechVacant lab space, shrinking workforce put Mass. in ‘unique position’ for biotech bouncebackMassBio's Industry Snapshot reported that Massachusetts biotech raised $3.45 billion in venture capital in the first half of 2026, up 25% year over year, with eight IPOs the most since 2021. R&D jobs fell about 3,600, or 3.1%, and average seed round size dropped nearly 40% to $4.6 million. Vacancy in lab space reached 31% as of mid-2026.BioSpaceOpinion: The FDA must put biotech at its center or continue to cede early research to ChinaThe CEO of MassBio argues in an opinion piece that the FDA's regulatory frameworks, designed for large established companies, are pushing biotech companies to conduct first-in-human clinical trials abroad, with none of 10 surveyed biotech executives currently running such trials in the U.S. The FDA and HHS recently launched Operation TrialBlazer to streamline the IND path and keep early clinical research in the U.S., but the author contends this initiative does not go far enough without dedicated emerging-biotech functions and real-time dialogue replacing written feedback. A cited MassBio survey found 55% of biotech executives found FDA written feedback ambiguous, and countries like China run early trial timelines 50-70% faster than the rest of the world.FierceBiotechBoston, China and the future of biotechA panel discussion was held at Fierce Biotech Week in Boston, bringing together senior representatives from Flagship Pioneering, PassKey, and MassBio to discuss the future of biotech innovation. The panelists debated topics including funding pressures, talent trends, AI in drug development, and growing competition from global biotech ecosystems. The discussion also explored what the industry can learn from China's rapid innovation model and whether biotech needs a fundamentally new operating model to accelerate bringing breakthrough science to patients.MassbioSummer Savings WeekMassBio is promoting its Summer Savings Week with a series of webinars, training, and networking events designed to help life sciences companies maximize savings and operational efficiency. The activities include partnerships with Fisher Scientific, Veolia, and Corporate Traveler, emphasizing cost reduction, safety, and member benefits.MassbioMassBio and SCbio launch Drive application for fall cohortsMassBio and SCbio announced that applications are now open for Fall 2026 cohorts of Drive, a national accelerator supporting scientific founders and early-stage biotech and techbio startups, with the program running September 14 to November 6, 2026. SCbio will facilitate the biotech cohort while MassBio will handle the techbio cohort, each tailoring program elements to their focus area. Since its 2022 launch, Drive has supported 70 early-stage companies that collectively raised $137 million in funding and created nearly 100 jobs.American City Business JournalsMassBio, Termeer Institute launch biotech leadership programMassBio and The Termeer Institute have launched Termeer Ascend, a leadership development program for senior biotech leaders aspiring to the C-suite, with the first cohort beginning this summer. The program addresses a critical talent gap, with over 90% of Massachusetts biopharma companies reporting difficulty hiring for non-entry-level roles and 86% lacking succession strategies for critical leadership positions. The initiative aims to diversify and strengthen the leadership pipeline in the state's life sciences ecosystem, which captured over a quarter of all U.S. biopharma venture capital in 2025.